- Home
- SHOT vs DYAI Comparison
SHOT vs DYAI Comparison
Compare SHOT & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOT
- DYAI
- Stock Information
- Founded
- SHOT 2018
- DYAI 1979
- Country
- SHOT United States
- DYAI United States
- Employees
- SHOT N/A
- DYAI N/A
- Industry
- SHOT Biotechnology: Pharmaceutical Preparations
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SHOT Health Care
- DYAI Health Care
- Exchange
- SHOT Nasdaq
- DYAI Nasdaq
- Market Cap
- SHOT 30.4M
- DYAI 31.3M
- IPO Year
- SHOT 2020
- DYAI 2004
- Fundamental
- Price
- SHOT $0.26
- DYAI $1.01
- Analyst Decision
- SHOT
- DYAI Strong Buy
- Analyst Count
- SHOT 0
- DYAI 1
- Target Price
- SHOT N/A
- DYAI $6.00
- AVG Volume (30 Days)
- SHOT 3.8M
- DYAI 40.5K
- Earning Date
- SHOT 05-15-2025
- DYAI 05-14-2025
- Dividend Yield
- SHOT N/A
- DYAI N/A
- EPS Growth
- SHOT N/A
- DYAI N/A
- EPS
- SHOT N/A
- DYAI N/A
- Revenue
- SHOT $573,336.00
- DYAI $3,554,344.00
- Revenue This Year
- SHOT N/A
- DYAI $78.01
- Revenue Next Year
- SHOT N/A
- DYAI N/A
- P/E Ratio
- SHOT N/A
- DYAI N/A
- Revenue Growth
- SHOT 69.32
- DYAI 57.59
- 52 Week Low
- SHOT $0.25
- DYAI $0.93
- 52 Week High
- SHOT $1.77
- DYAI $2.67
- Technical
- Relative Strength Index (RSI)
- SHOT 24.69
- DYAI 43.58
- Support Level
- SHOT $0.25
- DYAI $0.95
- Resistance Level
- SHOT $0.45
- DYAI $1.13
- Average True Range (ATR)
- SHOT 0.06
- DYAI 0.08
- MACD
- SHOT -0.02
- DYAI 0.01
- Stochastic Oscillator
- SHOT 3.24
- DYAI 53.10
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.